IVF culture medium and long-term child development by Zandstra, Heleen
  
 
IVF culture medium and long-term child development
Citation for published version (APA):
Zandstra, H. (2019). IVF culture medium and long-term child development. Maastricht: ProefschriftMaken
Maastricht. https://doi.org/10.26481/dis.20190201hz
Document status and date:
Published: 01/01/2019
DOI:
10.26481/dis.20190201hz
Document Version:
Publisher's PDF, also known as Version of record
Please check the document version of this publication:
• A submitted manuscript is the version of the article upon submission and before peer-review. There can
be important differences between the submitted version and the official published version of record.
People interested in the research are advised to contact the author for the final version of the publication,
or visit the DOI to the publisher's website.
• The final author version and the galley proof are versions of the publication after peer review.
• The final published version features the final layout of the paper including the volume, issue and page
numbers.
Link to publication
General rights
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright
owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these
rights.
• Users may download and print one copy of any publication from the public portal for the purpose of private study or research.
• You may not further distribute the material or use it for any profit-making activity or commercial gain
• You may freely distribute the URL identifying the publication in the public portal.
If the publication is distributed under the terms of Article 25fa of the Dutch Copyright Act, indicated by the “Taverne” license above,
please follow below link for the End User Agreement:
www.umlib.nl/taverne-license
Take down policy
If you believe that this document breaches copyright please contact us at:
repository@maastrichtuniversity.nl
providing details and we will investigate your claim.
Download date: 04 Dec. 2019
8
Valorisation

Valorisation
157
VALORISATION
In this valorisation paragraph the potential societal impact of the research presented 
in this thesis will be discussed. This thesis presents the results of a follow-up study in 
9-year-old children born after IVF. During an IVF treatment, embryos are cultured in cul-
ture medium that may contain a variety of different ingredients. We showed in a previous 
study that this culture medium can affect the birthweight of children born after IVF. It is 
also known that birthweight is an important parameter predicting future health risks, 
and therefore it is important to perform structured follow-up. In this thesis, we present 
the results of such a follow-up study. We showed that the group of children who were 
heavier at birth, were on average still heavier and had a higher BMI at 9 years of age if 
compared to the other group. Cardiovascular development and cognitive development 
were comparable. Our study was the first to show that culture medium can have an effect 
on postnatal development. 
Relevance
Since the first successful IVF treatment in 1978, the use of this treatment has increased 
significantly worldwide. In 2018, it was reported that already more than 8 million babies 
conceived after IVF/ICSI treatments were born. Research focusing on long-term health 
and development of the IVF offspring is still scarce. However, there is increasing evidence 
that pregnancies after ART are associated with a higher risk of adverse outcomes such 
as low birthweight and also that children born after ART show different outcomes with 
possible long-term health risks. We have shown that culture medium can affect not only 
birthweight, but also postnatal weight and growth patterns. Lower birthweight and accel-
erated postnatal growth are known to be associated with a higher risk for cardiovascular 
diseases in later life, which underlines the importance of structured and long-term follow 
up of the children born after IVF. 
Embryo culture media are an essential part of the IVF treatment and all cells within the 
embryo (and thus, indirectly, also all cells within the childs’ body) are exposed to the culture 
medium. At present, in contrast to the drugs used in IVF, there is no uniform regulation or 
statutory oversight of the composition of embryo culture media. In Europe, the majority 
of media carry the CE mark, but non-CE media can still be used. Overall, fertility centers 
choose the media they want to use according to their own preferences. Manufacturers 
differ on whether and how they give information on the composition of the culture media 
and the scientific rationale. They are allowed to change their composition without inform-
ing their end-users (embryologists) about the changes. In the EU covenant of 2009 it was 
agreed that the EU would regulate ART culture media and consider them medical devices 
(Class III). According to the EU medical device regulations, manufacturers are supposed 
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to perform structured and long-term follow-up of the offspring who as an embryo were 
cultured in their culture media, however this is not performed. It is worrisome that the 
exact quantitative composition is unknown, because this limits the option to correlate 
specific culture medium ingredients to IVF outcome. The strong financial aspect of this 
field has led to a lack of transparency regarding composition, which does not facilitate 
the scientific effort to refine IVF culture media and reach a consensus on which one to 
use in which circumstances. 
Target groups
The results of this thesis are interesting mostly for IVF clinicians, embryologists and embryo 
culture medium manufacturers. In the future, it could also be potentially useful for health 
economists, insurance companies and politicians. The results are only to a limited extent 
interesting for couples that are currently undergoing fertility treatment or already have 
a child conceived via IVF. Since it is still very unclear to what extent culture media can 
influence outcome, and moreover, which culture medium (ingredient) would be better, 
it is too early to inform patients about this. Patients should be informed that the general 
health outcome of children born after IVF is reassuring, but that all techniques that are 
applied during the embryonic phase are possibly capable of creating an increase in risks 
in later life.
 
Activities/Innovations 
All chapters in this thesis have been or will be published in high-ranked scientific journals. 
Also, we have discussed our findings at numerous national and international conferences 
to increase awareness and attention for this important topic. Also the findings were dis-
cussed in popular scientific journals and newspapers (New Scientist and Daily Mail) that are 
easy accessible to patients and other people interested in IVF. We are currently performing 
a new multicenter randomized controlled trial to compare pregnancy and perinatal out-
come between a sequential culture medium and a single-step culture medium to increase 
the knowledge and corroborate the evidence on their effects.
The European Society of Human Reproduction and Embryology (ESHRE) has appointed a 
working group on culture media with members from the special interest groups Embryol-
ogy, Safety and Quality in ART, and Genetics. This working group encourages constructive 
co-operations with IVF culture media manufacturers regarding transparency, composition 
and quality control parameters. Also, in 2016 the Oxford University Press published a 
press release in Human Reproduction from the working group that received worldwide 
attention. The results of our study will be presented to this working group and will add 
valuable information and therefore enforce the working groups’ position in the lobby with 
manufacturers to become transparent on the composition of their culture media. 
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It is very important to acknowledge the possibility that IVF culture media composition, 
other culture conditions and techniques applied during the IVF treatment can affect post-
natal development of the offspring. However, the extent of the adverse outcome is still 
uncertain and large basic research studies and randomized clinical studies are essential 
to investigate the aetiology of the adverse outcome. 
Schedule and implementation
Introduction of new techniques, changes in culture media composition and laboratory 
protocols should be preceded by thorough and structured research upon introduction 
into daily practice. In reproductive medicine not infrequently a treatment forces itself 
upon the practitioner long before a suitable theory of the mechanism of action has 
been developed. Too often, new techniques are introduced into daily practice after just 
some appealing findings in a few small, underpowered, mostly observational studies. 
Well-designed and properly powered research is indispensible for improving the tech-
niques used in IVF. With regard to culture media development, changes should be made 
to the existing regulatory system to achieve transparency and improve monitoring of 
outcomes to the long-term benefit of ART children. At the moment, only basic quality 
control and a proof-of-principle from mouse embryo testing is necessary before a new 
culture medium can be applied in the human IVF clinic. This is not enough to safeguard 
the health of future IVF children.
An important step forward would be that researchers are allowed to culture embryos 
just for research purposes. Animal models are in many ways a very good first step for 
research in the field of reproductive medicine, but the results might not always translate 
well to the human situation. The most important advantage of animal research is the 
shorter lifespan of for example mice, with a timespan of a couple of months “long-term” 
effects of culture medium can be investigated. However, humans have a fecundity that 
is not at all comparable to that of mice and sheep and also there are differences in the 
nutritional requirements of the embryos. Therefore animal models should not be the 
only way to gain more insight in the (patho)physiology and to test effectiveness of new 
techniques, but it should also be performed in human embryos. Unfortunately in The 
Netherlands, it is not allowed to culture embryos for research and in the latest political 
coalition agreement, in October 2017, the new Government announced that this will 
not be allowed for at least the next 4 years. This is a great set-back for research in the 
field of ART and it should be carefully reconsidered. In comparison to culture media for 
mouse embryos, media for human embryos are not truly optimized and probably will 
never be without proper research in human embryos. In order to optimize basic culture 
parameters for mice, to optimize mouse embryo culture medium, several thousand 
mouse embryos were used. To achieve similar experiments in humans, the number 
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of human embryos would be very high and numerous ethical issues would be raised. 
However the consequence of this is the introduction of embryo culture media without 
proper testing in the human.
Challenges involved in the field of reproductive medicine
Although ART has changed the life of many people in a positive way, it is also an increas-
ingly commercial industry. Couples who are trying to conceive are willing to try anything 
to achieve their biggest wish, i.e. becoming parents. The field of ART is rapidly changing 
and improving, but many new technologies and methods have been introduced in clinical 
practice without appropriate evidence to show that the procedure is beneficial to the 
patient and moreover that the benefits outweigh its potential harms. The biggest differ-
ence with other fields in medicine is that fertility patients attend clinics with a “wish” instead 
of a “complaint”. Their attitude is therefore quite different from patients who attend their 
doctor for example for high blood pressure. Infertility patients are often well informed, 
either by reading on the internet but also by taking in a lot of (not always correct) advice 
from their friends and family. Professionals involved in IVF treatments should inform their 
patients carefully and the main objective should be to be honest about the (im)possibility 
and usefulness of adding extra techniques. Shared decision making together with well-in-
formed couples is one of the challenges of IVF clinicians. 
We hope that the results described in this thesis will increase awareness for the existing 
legislation and most importantly more strict regulations concerning the clinical implemen-
tation of culture media. More stringent regulation on the production of IVF culture media 
and more flexible legislation on embryo research is required to keep moving forward with 
the best interest of the patients and their offspring in mind. It is the duty of healthcare 
professionals and researchers to focus on unravelling the aetiology of the observed dif-
ferences to be able to improve the techniques in order to reduce the potential lifetime 
health risks of the IVF offspring.


